| Literature DB >> 29072626 |
Li Yang1, Shu-Tai Jiang2, Qin-Guang Zhou3, Guo-Yue Zhong4, Jun-Wei He5.
Abstract
Two new phenolic glucosides, hostaflavanone A (1) and anti-1-phenylpropane-1,2-diol-2-O-β-d-glucopyranoside (2), together with six known compounds, anti-1-phenylpropane-1,2-diol (3), phenethyl-O-β-d-glucopyranoside (4), phenethanol-β-d-gentiobioside (5), phenethyl-O-rutinoside (6), (1S, 3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (7), and (1R, 3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (8), were isolated from the flower of Hosta plantaginea, and their structures were elucidated by nuclear magnetic resonance (NMR), high resolution electrospray ionization mass spectroscopy (HRESIMS), and circular dichroism (CD) analyses. The cyclooxygenases (COX-1 and COX-2) inhibition and antioxidant activities of compounds 1 and 4-6 were investigated, and they showed moderate cyclooxygenases inhibition activities. Moreover, only compound 1 exhibited moderate antioxidant activity, with an IC50 value of 83.2 μM, while 4-6 showed insignificant activity with IC50 values of 282, 257, and 275 μM, respectively. This is the first report of compounds 3 and 5-8 from the Liliaceae family. The chemotaxonomic significance of the isolated compounds was also summarized.Entities:
Keywords: Hosta plantaginea; antioxidant; chemical constituents; chemotaxonomics; cyclooxygenase inhibition
Mesh:
Substances:
Year: 2017 PMID: 29072626 PMCID: PMC6150378 DOI: 10.3390/molecules22111825
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of compounds 1–8.
13C- and 1H-NMR data for compounds 1 and puddumin A in DMSO-d6 (δ in ppm).
| Position | 1 | Puddumin A | ||
|---|---|---|---|---|
| 2 | 78.3 | 5.40 (1H, m) | 78.3 | 6.15 (1H, s) |
| 3 | 44.7 | 3.07 (1H, dd, | 44.5 | 3.30 (1H, d, |
| 2.57 (1H, dd, | 2.70 (1H, s) | |||
| 4 | 188.3 | - a | 192.4 | - a |
| 5 | 161.7 | - a | 159.9 | - a |
| 6 | 94.0 | 6.28 (1H, d, | 93.7 | 6.40 (1H, d, |
| 7 | 163.3 | - a | 165.6 | - a |
| 8 | 96.1 | 6.24 (1H, d, | 95.1 | 6.78 (1H, d, |
| 9 | 164.1 | - a | 165.1 | - a |
| 10 | 106.1 | - a | 106.5 | - a |
| 1′ | 129.1 | - a | 126.0 | - a |
| 2′, 6′ | 128.3 | 7.30 (2H, d, | 130.8 | 7.65 (2H, d, |
| 3′, 5′ | 115.2 | 6.79 (2H, d, | 115.9 | 6.83 (2H, d, |
| 4′ | 157.7 | - a | 159.6 | - a |
| 1′′ | 99.7 | 4.99 (1H, d, | 100.3 | - b |
| 2′′ | 73.1 | 3.23 (1H, m) | 73.3 | - b |
| 3′′ | 76.5 | 3.28 (1H, m) | 76.8 | - b |
| 4′′ | 69.7 | 3.14 (1H, m) | 69.6 | - b |
| 5˝ | 77.2 | 3.39 (1H, m) | 77.5 | - b |
| 6′′ | 60.7 | 3.68 (1H, m) | 60.6 | |
| 3.43 (1H, m) | b | |||
| 5-OCH3 | 55.9 | 3.78 (3H, s) | 55.5 | 3.80 (3H, s) |
a no signal; b not assigned.
Figure 2Selected 1H-1H COSY and HMBC correlations of 1.
Figure 3CD spectrum of compound 1 in CH3OH.
13C- and 1H-NMR data for compounds 2 and 3 in DMSO-d6 (δ in ppm).
| Position | 3 | 2 | ||
|---|---|---|---|---|
| 1 | 76.1 | 4.48 (1H, d, | 78.6 | 4.43 (1H, d, |
| 2 | 69.4 | 4.41 (1H, m) | 73.7 | 4.40 (1H, m) |
| 3 | 19.1 | 1.08 (3H, d, | 16.5 | 1.16 (3H, d, |
| 1′ | 140.3 | 140.1 | ||
| 2′, 6′ | 127.8 | 7.15–7.26 (5H, m) | 127.9 | 7.16-7.26 (5H, m) |
| 3′, 5′ | 129.3 | 7.15–7.26 (5H, m) | 129.3 | 7.16-7.26 (5H, m) |
| 4′ | 125.5 | 7.15–7.26 (5H, m) | 125.6 | 7.16-7.26 (5H, m) |
| 1′′ | - b | - b | 102.9 | 4.23 (1H, d, |
| 2′′ | - b | - b | 73.5 | - a |
| 3′′ | - b | - b | 76.4 | - a |
| 4′′ | - b | - b | 70.1 | - a |
| 5′′ | - b | - b | 76.8 | - a |
| 6′′ | - b | - b | 61.0 | - a |
a not assigned; b no signal.
In vitro COX-1/COX-2 inhibition and antioxidant activities of isolated compounds.
| Compounds | IC50 (μM) | SI d | ||
|---|---|---|---|---|
| COX-1 a | COX-2 a | Antioxidant b | ||
| 21.6 ± 1.2 | 45.4 ± 3.3 | 83.2 ± 3.0 | 0.48 | |
| 15.5 ± 0.6 | 38.2 ± 3.9 | 282 ± 5.2 | 0.41 | |
| 38.4 ± 1.3 | 31.7 ± 2.9 | 257 ± 13.8 | 1.16 | |
| 41.2 ± 1.5 | 35.4 ± 1.6 | 275 ± 14.8 | 1.21 | |
| celecoxib | 9.0 ± 0.6 | 1.0 ± 0.1 | - c | 9.00 |
| - c | - c | 33.9 ± 1.1 | - c | |
a Meaning the 50% inhibition concentration of isolated compounds calculated from regression using five different concentrations (100, 50, 25, 12.5, 6.25 μM); b Meaning the 50% inhibition concentration of isolated compounds calculated from regression using five different concentrations (500, 200, 100, 50, 25 μM); c Not determined; d SI (Selectivity Index) = IC50 (COX-1)/IC50 (COX-2).